Skip to content

Study on the treatment method of moderate to severe keratosis pilaris

A study of treatment approaches for moderate to severe keratosis pilaris: a self-controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054489
Enrollment
Unknown
Registered
2021-12-18
Start date
2021-12-18
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratosis Pilaris

Interventions

Group A:Long Pulse 755nm Alexandrite Laser
Group B:AHA and Q-switched Nd:YAG (1064nm) Laser

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Informed consent to participate in clinical trials and be able to receive follow-up; 2. In line with the diagnosis of keratosis pilaris, and there are skin lesions of keratosis pilaris on both upper arms; 3. Aged >=18 years, < 65 years; 4. In good health.

Exclusion criteria

Exclusion criteria: 1. Received any systemic or topical drug treatment within 12 months before recruitment; 2. Received any laser treatment within 12 months before recruitment; 3. Being diagnosed with another skin condition or malignant tumor at the same time; 4. Tanning or sunburn on the upper arm one month before recruitment; 5. Open ulcers or infections on any skin site; 6. Have used topical or oral photosensitizers; 7. Pregnant or lactating patients.

Design outcomes

Primary

MeasureTime frame
Blinded Rater's Scores;

Secondary

MeasureTime frame
Patient Self-assessment Scores;Skin histopathology;Dermoscopy;High-frequency ultrasound;Adverse effect;

Countries

China

Contacts

Public ContactZhuo Fenglin
770972657@qq.com+86 15910895068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026